Last updated: October 30, 2024
Sponsor: Centre Hospitalier Universitaire de Nice
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Passage of olfactory tests
Clinical Study ID
NCT06386523
23-AOI-03
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subjects > 18 years old
No olfactory complaints; subjective estimation of "normal" olfaction
Affiliated to the Social Security system
Signing of informed consent
Exclusion
Exclusion Criteria:
Parosmia/phantosmia, hyposmia/anosmia, pre-existing subjective dysgeusia/ageusia
ATCD of sinus or cranial neoplasia
ATCD of sinus or cranial radiotherapy
Neurological or neurodegenerative disease
ATCD of persistent post-viral hyposmia or anosmia (including COVID) (more than 3months)
Study Design
Total Participants: 112
Treatment Group(s): 1
Primary Treatment: Passage of olfactory tests
Phase:
Study Start date:
October 21, 2024
Estimated Completion Date:
April 21, 2026
Study Description
Connect with a study center
CH de Cannes
Cannes,
FranceActive - Recruiting
CHU de Nice
Nice,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.